In melanoma, BAD is phosphorylated through MEK/ERK dependent signalling, supporting cell survival, this is an adaptation from melanocytes where these phosphorylation’s are mainly driven by the RSK signalling pathway (Eisenmann et al., 2003). This evidence concerns the gene MAP2K7 and melanoma.